Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome

Neurology

Volumn 65, Issue 9, 2005, Pages 1376-1381

  Koga, M ^a   Takahashi, M ^b   Masuda, M ^a   Hirata, K ^a   Yuki, N ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; AUTOANTIBODY; EPITOPE; GANGLIOSIDE; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GANGLIOSIDE GQ 1B; IMMUNOGLOBULIN G ANTIBODY; LIPOOLIGOSACCHARIDE; THREONINE;

ARTICLE; ATAXIA; AUTOIMMUNITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CAMPYLOBACTER JEJUNI; CLINICAL FEATURE; CST II GENE; ENTERITIS; GENETIC POLYMORPHISM; GUILLAIN BARRE SYNDROME; HOST; HUMAN; INFECTION COMPLICATION; MOLECULAR MIMICRY; MUSCLE WEAKNESS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPHTHALMOPLEGIA; PATHOGENESIS; PRIORITY JOURNAL;

EID: 27644479846     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000176914.70893.14     Document Type: Article

References (42)

1. Ropper AH. The Guillain-Barré syndrome. N Engl J Med 1992;326:1130-1136.
2. Ogawara K, Kuwabara S, Mori M, et al. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000;48:624-631.
3. Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993;43:1911-1917.
4. Jacobs BC, Rothbarth PH, van der Meché FGA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998;51:1110-1115.
5. Yuki N, Taki T, Inagaki F, et al. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 gangliosido-like structure. J Exp Med 1993;178:1771-1775.
6. Aspinall GO, McDonald AG, Pang H, et al. Lipopolysaccharides of Campylobacter jejuni serotype O:19 structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with Guillain-Barré syndrome. Biochemistry 1994;33:241-249.
7. Shin JE, Sckloo S, Mainkar, et al. Lipo-oligosaccharides of Campylobacter jejuni serotype O:10: structures of core oligosaccharide regions from a bacterial isolate from a patient with the Miller-Fisher [sic] syndrome and from the serotype reference strain. Carbohydr Res 1998;305:223-232.
8. Yuki N, Susuki K, Koga M, et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipo-oligosaccharide causes Guillain-Barré syndrome. Proc Natl Acad Sci USA 2004;101:11404-11409.
9. Parkhill J, Wren BW, Mungall K, et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000;403:665-668.
10. 13C NMR analysis. J Biol Chem 2000;275:3896-3906.
11. Svennerholm L. Chromatographic separation of human brain gangliosides. J Neuroehem 1963;10:613-623.
12. Guerry P, Ewing CP, Hickey TE, et al. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance cf Campylobacter jejuni. Infect Immun 2000;68:6656-6662.
13. van Belkum A, van den Braak N, Godschalk P. Campylobacter jejuni gene associated with immune-mediated neuropathy. Nat Med 2001;7:752-753.
14. Nachamkin I, Liu J, Li M, et al. Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD1a-like epitope. Infect Immun 2002;70:5299-5303.
15. Gilbert M, Karwaski M-F, Bernatchez S, et al. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni: biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J Biol Chem 2002;277:327-337.
16. Odaka M, Yuki N, Yamada M, et al. Bickerstaffs brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome. Brain 2003;126:2279-2290.
17. Yuki N, Odaka M, Hirata K. Acute ophthalmoparesis (without ataxia) associated with anti-GQ1b IgG antibody: clinical features. Ophthalmology 2001;108:196-200.
18. O'Leary CP, Veitch J, Durward WF, et al. Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. J Neurol Neurosurg Psychiatry 1996;61:649-651.
19. Takahashi M, Koga M, Yokoyama K, Yuki N. Epidemiology of Campylobacter jejuni isolated from patients with Guillain-Barré and Fisher syndromes in Japan. J Clin Microbiol 2005;43:335-339.
20. Yuki N, Tsujino Y. Familial Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J Pediatr 1995;126:162.
21. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):821-24.
22. Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001;70:50-55.
23. Yuki N, Tagawa Y, Irie F, et al. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J Neuroimmunol 1997;74:30-34.
24. Yuki N, Yoshino H, Sato S, Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 1990;40:1900-1902.
25. Rees JH, Gregson NA, Hughes RAC. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship tc Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.
26. Hitchcock PJ, Brown TM. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J Bacteriol 1983;154:269-277.
27. Koga M, Gilbert M, Li J, et al. Antecedent infections; in Fisher syndrome. A common pathogenesis of molecular mimicry. Neurology 2005;64:1605-1611.
28. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfatepolyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to100 kDa. Anal Biochem 1987;166:368-379.
29. Stollerman GH. Rheumatic fever. Lancet 1997;349:935-942.
30. Willison HJ, Yuki N. Peripheral neuropathies and anti-glycolipid antibodies. Brain 2002;125:2591-2625.
31. Endtz HP, Ang CW, van den Braak N, et al. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. J Clin Microbiol 2000;38:2297-2301.
32. Duim B, Ang CW, van Belkum A, et al. Amplified fragment length polymorphism analysis of Campylobacter jejuni strains isolated from chickens and from patients with gastroenteritis or Guillain-Barré or Miller Fisher syndromes. Appl Environ Microbiol 2000;56:3917-3923.
33. Engberg J, Nachamkin I, Fussing V, et al. Absence of clonality of Campylobacter jejuni in serotypes other than HS: 19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis 2001;184:215-220.
34. Nachamkin I, Engberg J, Gutacker M, et al. Molecular population genetic analysis of Campylobacter jejuni HS: 19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis 2001;184:221-226.
35. Leonard II EE, Tompkins LS, Falkow S, Nachamkin I. Comparison of Campylobacter jejuni isolates implicated in Guillain-Barré syndrome and strains that cause enteritis by a DNA microarray. Infect Immun 2004;72:1199-1203.
36. Godschalk PCR, Heikema AP, Gilbert M, et al. The crucial role of Campylobacter jejuni genes in autoimmune antibody induction. J Clin Invest 2004;114:1659-1665.
37. Mori M, Kuwabara S, Miyake M, et al. Haemophilus influenzae infection and Guillain-Barré syndrome. Brain 2000;123:2171-2178.
38. Mandrell RE, McLaughlin R, Abu Kwaik Y, et al. Lipooligosaccharides (LOS) of some Haemophilus species mimic human glycosphingolipids, and some LOS are sialylated. Infect Immun 1992;60:1322-1328.
39. Hood DW, Cox AD, Gilbert M, et al. Identification of a lipopolysaccharide α-2,3-sialyltransferase from Haemophilus influenzae. Mol Microbiol 2001;39:341-350.
40. Jones PA, Samuels NM, Phillips NJ, et al. Haemophilus influenzae type b strain A2 has multiple sialyltransferases involved in lipooligosaccharide sialylation. J Biol Chem 2002;277:14598-14611.
41. Ang CW, Laman JD, Willison HJ, et al. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Infect Immun 2002;70:1202-1208.
42. Ang CW, Noordzij PG, de Klerk MA, et al. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits. Infect Immun 2002;70:5081-5085.